Company Overview
Healthcare Services Group, Inc. provides specialized management, administrative, and operating services to the housekeeping, laundry, linen, facility maintenance, and dietary service departments within nursing homes, retirement complexes, rehabilitation centers, and hospitals across the United States. The company operates within the Healthcare sector, specifically classified under the Medical Care Facilities industry, which reflects its focus on essential support services for long-term care and acute medical environments. This operational scale is evidenced by a market capitalization of $1.37B and an annual revenue of $1.84B, supported by a workforce of 36000 employees. These valuation and revenue figures indicate that the company holds a significant position as a major provider of outsourced services, capable of generating substantial top-line income while maintaining a substantial asset base to support its extensive labor force.
Financial Health
The company reported a total revenue of $1.84B over the trailing twelve months, generating a net income of $59.06M and an EBITDA of $57.02M. The gap between the $1.84B revenue and the $59.06M net income reveals a cost structure where operating expenses, including labor for housekeeping and maintenance, consume the majority of gross receipts before reaching the bottom line. The business generated $74.72M in free cash flow, which provides the financial flexibility to fund operations, maintain its extensive facility portfolio, or pursue strategic initiatives without relying on external capital. Gross margins stand at 13.0%, indicating that the nature of the services involves high variable costs relative to sales, while operating margins of 5.5% and profit margins of 3.2% further illustrate the operational leverage required to convert revenue into earnings. On the balance sheet, the company holds $167.96M in cash against $15.02M in debt, resulting in a debt-to-equity ratio of 2.94, which suggests a leveraged position where equity financing is a primary source of capital relative to obligations. Despite the debt load, a current ratio of 3.38 indicates robust short-term liquidity, ensuring the company can comfortably meet its immediate obligations with its available current assets. Additionally, the return on equity is 11.7% and the return on assets is 3.8%, metrics that reveal how effectively management utilizes shareholder capital and total assets to generate returns, with the ROE significantly outperforming the ROA due to the leverage present in the capital structure.
Valuation Assessment
The stock trades with a trailing P/E ratio of 23.93 and a forward P/E of 17.65, implying that the market expects earnings growth to be strong enough to justify a lower valuation multiple in the future compared to historical performance. The price-to-book ratio is 2.64, which indicates that the market values the company at a significant premium over its net book value, reflecting expectations of future growth or intangible assets not fully captured on the balance sheet. Alternative valuation metrics include a price-to-sales ratio of 0.74 and an EV/EBITDA of 21.20, suggesting that while the stock trades at less than one dollar of sales, the enterprise value relative to cash flow remains elevated. Regarding trading range, the 52-week high is $22.98 and the 52-week low is $9.13, meaning the current price sits below the high but above the low, reflecting recent volatility within the healthcare services sub-sector. The beta value is 0.75, indicating that the stock price is less volatile than the broader market, offering a degree of stability often sought in defensive healthcare plays.
Growth & Income
Revenue growth stands at 6.6% year-over-year, while earnings growth is substantially higher at 172.4%, implying that the company is improving its operational efficiency or benefiting from margin expansion that allows earnings to outpace top-line revenue increases. As the company does not pay a dividend, indicated by a dividend yield of N/A and a payout ratio of 0.0%, it reinvests all available earnings back into the business rather than distributing cash to shareholders. This approach to capital allocation suggests a focus on funding growth initiatives, such as expanding service contracts or upgrading facilities, rather than providing current income to investors. The overall growth and income profile is characterized by significant earnings acceleration and a zero-dividend policy, positioning the stock primarily as a growth vehicle rather than an income investment within the healthcare services landscape.